To explain the medical options, epidemiology, autoantibody standing, HLA haplotypes and genetic mechanisms of sort 1 diabetes mellitus (T1DM). Sufferers (0-18 years) with diabetes had been recruited. Scientific knowledge was collected, autoantibodies and c-peptide had been measured.

Complete Genome Sequencing was carried out. Genomic knowledge evaluation was in contrast with the recognized genes linked with T1DM and HLA alleles had been studied. 1096 sufferers had a number of antibody positivity. The incidence of T1DM in 2020 was 38.05 per 100,000 kids and prevalence was 249.73.

GADA was the commonest autoantibody adopted by IAA. Variants in GSTCD, SKAP2, SLC9B1, BANK1 had been most prevalent. An affiliation of HLA haplotypes DQA1*03:01:01G (OR = 2.46, p worth = 0.011) and DQB1*03:02:01G (OR = 2.43, p worth = 0.022) was recognized.

The incidence of T1DM in Qatar is the fourth highest on the planet, IA2 autoantibody was probably the most particular with some sufferers solely having ZnT8 or IA2 autoantibodies thus underlining the need of profiling all Four autoantibodies.

The genes related to T1DM within the Arab inhabitants had been totally different from these which are frequent within the Caucasian inhabitants. HLA-DQ was enriched within the Qatari sufferers suggesting that it may be thought of a serious threat issue at an early age.

Kind 2 diabetes (T2D) is among the commonest power metabolic problems in maturity worldwide, whose pathophysiology contains an irregular immune response accompanied by cytokine dysregulation and irritation. The chance and outcomes of diabetes in sufferers with epilepsy stays unclear.

Because the T2D-related irritation and its development had been related to the steadiness between professional and anti inflammatory cytokines, anticytokine remedies would possibly signify an extra therapeutic possibility for T2D sufferers.

This evaluate focuses on current proof for antihyperglycemic properties of disease-modifying antirheumatic medication (DMARDs) and anticytokine brokers (anti-TNF-α, anti-interleukin-(IL-) 6, -IL-1, -IL-17, -IL-23, and so forth.). Emphasis is positioned on their molecular mechanisms and on the organic rationale for medical use.

Lastly, we briefly summarize the outcomes from experimental mannequin research and promising medical trials in regards to the potential of anticytokine therapies in T2D, discussing the results of those medication on systemic and islet irritation, beta-cell operate, insulin secretion, and insulin sensitivity.

Danger and outcomes of diabetes in sufferers with epilepsy

We evaluated these dangers utilizing an epilepsy cohort evaluation and a diabetes admission evaluation. Within the epilepsy cohort evaluation, we recognized 2854 sufferers with newly identified epilepsy in 2000-2008 from the analysis knowledge of Nationwide Well being Insurance coverage in Taiwan.

Utilizing Propensity-score matching by sociodemographic elements and medical situations, we chosen 22,832 folks with out epilepsy as a non-exposed cohort for comparability. Comply with-up occasions of diabetes from January 1, 2000 till December 31, 2013 had been ascertained from medical claims.

The adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of diabetes related to epilepsy had been calculated utilizing a number of Cox proportional hazard fashions. Within the diabetes admission evaluation, we recognized 92,438 hospitalized diabetes sufferers, 930 of whom had a historical past of epilepsy.

Adjusted odds ratios (ORs) and 95% CIs of antagonistic occasions after diabetes related to earlier epilepsy had been calculated utilizing a number of logistic regressions. The adjusted HR of diabetes within the cohort with epilepsy was 1.31 in comparison with the non-epilepsy cohort.

Earlier epilepsy was related to post-diabetes antagonistic occasions, comparable to pneumonia, urinary tract an infection, and septicemia. In conclusion, epilepsy was related to increased threat of diabetes and antagonistic post-diabetes outcomes. Diabetes prevention and a focus to post-diabetes antagonistic occasions are wanted for this inclined inhabitants.

Non-Alcoholic Fatty Liver Illness and Its Affiliation With Diabetes Mellitus

There’s a bidirectional relationship between non-alcoholic fatty liver illness (NAFLD) and sort 2 diabetes mellitus (T2DM). The liver has an important function within the pathophysiology of each illnesses because it results in the event of insulin resistance (IR), which in flip leads to NAFLD and T2DM.

It has been proven that T2DM will increase the danger of NAFLD development. Moreover, the presence of NAFLD raises the chance of T2DM problems, which explains the elevated charges of NAFLD screening in sufferers with T2DM. As well as, there are frequent administration choices for the 2 illnesses.

Way of life adjustments can play a job within the preliminary administration of each illnesses. Medicines which are used to deal with T2DM are additionally used within the administration of NAFLD, comparable to metformin, thiazolidinediones (TZD), glucagon-like peptide-1 (GLP-1) analogues, and dipeptidyl peptidase-4 (DPP4) inhibitors.

Bariatric surgical procedure is commonly used as a final resort and has proven promising outcomes. Way of life interventions with weight-reduction plan and train are vital postoperatively to take care of the load loss. There are numerous novel remedies which are being investigated for the remedy of NAFLD, concentrating on a number of pathophysiologic pathways.

This evaluate goals to shed some gentle on the intricate relationship between NAFLD and T2DM and the way IR hyperlinks each illnesses. We additionally attempt to elevate consciousness amongst clinicians about this relationship and the way the presence of 1 illness ought to elevate a excessive index of suspicion for the existence of the opposite.Clinical features, epidemiology, autoantibody status, HLA haplotypes and genetic mechanisms of type 1 diabetes mellitus among children in Qatar

The impact of guar gum consumption on the lipid profile in sort 2 diabetes mellitus: a scientific evaluate and meta-analysis of randomized managed trials

Dyslipidemia is a typical encounter in sort 2 diabetes mellitus (T2DM) and the present methods to handle it are nonetheless suboptimal. Subsequently, figuring out newer molecules with lipid-lowering results is critical. A substantial amount of consideration has been given lately to fiber dietary supplements, e.g., guar gum.

Thus, we screened and evaluated the standard of the proof relating to the advantages of guar gum supplementation in T2DM and carried out a meta-analysis to evaluate the results of this compound on serum lipids in T2DM.

RAD Antibody
34723-100ul 100ul
EUR 252
RAD Antibody
34723-50ul 50ul
EUR 187
RAD Antibody
DF4104 200ul
EUR 304
Description: RAD Antibody detects endogenous levels of total RAD.
GTP-Binding Protein RAD (RAD) Antibody
20-abx014514
  • EUR 314.00
  • EUR 98.00
  • EUR 398.00
  • EUR 495.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg
  • Shipped within 5-10 working days.
RAD Conjugated Antibody
C34723 100ul
EUR 397
Anti-RAD Antibody
A30715 100ul
EUR 397
Description: Rabbit Polyclonal RAD Antibody. Validated in IF, IHC, WB and tested in Human.
Rad GTPase Polyclonal Antibody
ES3302-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against Rad GTPase from Human. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA
Rad GTPase Polyclonal Antibody
ES3302-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against Rad GTPase from Human. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA
Rad GTPase Polyclonal Antibody
ABP52303-003ml 0.03ml
EUR 158
  • Immunogen information: Synthesized peptide derived from the Internal region of human Rad GTPase at AA range: 10-90
  • Applications tips:
Description: A polyclonal antibody for detection of Rad GTPase from Human. This Rad GTPase antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Rad GTPase at AA range: 10-90
Rad GTPase Polyclonal Antibody
ABP52303-01ml 0.1ml
EUR 289
  • Immunogen information: Synthesized peptide derived from the Internal region of human Rad GTPase at AA range: 10-90
  • Applications tips:
Description: A polyclonal antibody for detection of Rad GTPase from Human. This Rad GTPase antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Rad GTPase at AA range: 10-90
Rad GTPase Polyclonal Antibody
ABP52303-02ml 0.2ml
EUR 414
  • Immunogen information: Synthesized peptide derived from the Internal region of human Rad GTPase at AA range: 10-90
  • Applications tips:
Description: A polyclonal antibody for detection of Rad GTPase from Human. This Rad GTPase antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Rad GTPase at AA range: 10-90
Anti-Rad GTPase antibody
STJ95321 200 µl
EUR 197
Description: Rabbit polyclonal to Rad GTPase.
RAD Blocking Peptide
DF4104-BP 1mg
EUR 195
GTP-Binding Protein RAD (RRAD) Antibody
20-abx008742
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul
  • Shipped within 5-10 working days.
GTP-binding protein RAD (RRAD) Antibody
20-abx324872
  • EUR 314.00
  • EUR 244.00
  • 100 ug
  • 50 ug
  • Shipped within 5-10 working days.
GTP-binding protein RAD (RRAD) Antibody
20-abx214509
  • EUR 411.00
  • EUR 300.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.
GTP-binding protein RAD (RRAD) Antibody
abx332370-100ul 100 ul
EUR 425
  • Shipped within 5-10 working days.
GTP-Binding Protein RAD (RRAD) Antibody
abx432011-200ul 200 ul
EUR 384
  • Shipped within 1-3 working days.
GTP-binding protein RAD (RRAD) Antibody
20-abx241706
  • EUR 411.00
  • EUR 300.00
  • 100 ul
  • 50 ul
  • Shipped within 5-10 working days.
Mouse GTP- binding protein RAD, Rrad ELISA KIT
ELI-14089m 96 Tests
EUR 865
Human GTP- binding protein RAD, RRAD ELISA KIT
ELI-35549h 96 Tests
EUR 824
Human GTP-binding protein RAD (RRAD) ELISA Kit
abx385354-96tests 96 tests
EUR 911
  • Shipped within 5-12 working days.
Mouse GTP-binding protein RAD (RRAD) ELISA Kit
abx390415-96tests 96 tests
EUR 911
  • Shipped within 5-12 working days.
Rat GTP-binding protein RAD (RRAD) ELISA Kit
abx391893-96tests 96 tests
EUR 911
  • Shipped within 5-12 working days.
Recombinant Caenorhabditis Elegans rad-50 Protein (aa 1-1298)
VAng-Ly3634-inquire inquire Ask for price
Description: Caenorhabditis Elegans DNA repair protein rad-50 (rad-50), partial, recombination protein.
Rrad ELISA Kit| Rat GTP-binding protein RAD ELISA Kit
EF019253 96 Tests
EUR 689
Rad21l1 ELISA Kit| Mouse Double-strand-break repair protein rad
EF016034 96 Tests
EUR 689
Rrad ELISA Kit| Mouse GTP-binding protein RAD ELISA Kit
EF016057 96 Tests
EUR 689
Sealing film, qPCR Optical (sticky adhesive film) Bio-Rad Type, 100/pk
P1001-Q 100/pack
EUR 122.9
Description: Sealing film qPCR Optical (sticky adhesive film) Bio-Rad Type
Anti-Dnmt3b Rabbit Monoclonal Antibody Rabbit Monoclonal Antibody
M00319 100ug/vial
EUR 397
Description: Rabbit Monoclonal Dnmt3b Antibody Antibody. Validated in IF, ICC, WB and tested in Human, Mouse, Rat.
Rabbit Tpa Antibody
abx023929-02mg 0.2 mg
EUR 606
  • Shipped within 5-10 working days.
Rabbit Albumin Antibody
40150-05011 150 ug
EUR 217
Anti-Rabbit antibody
STJ11100323 100 µl
EUR 277
p40(Rabbit PAb) Antibody
BNC610375-100 100uL
EUR 199
Description: Primary antibody against p40(Rabbit PAb), CF660R conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC610375-500 500uL
EUR 544
Description: Primary antibody against p40(Rabbit PAb), CF660R conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC610385-100 100uL
EUR 199
Description: Primary antibody against CD3e(Rabbit PAb), CF660R conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC610385-500 500uL
EUR 544
Description: Primary antibody against CD3e(Rabbit PAb), CF660R conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC610386-100 100uL
EUR 199
Description: Primary antibody against CD8a(Rabbit PAb), CF660R conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC610386-500 500uL
EUR 544
Description: Primary antibody against CD8a(Rabbit PAb), CF660R conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC610408-100 100uL
EUR 199
Description: Primary antibody against TIMP3(Rabbit PAb), CF660R conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC610408-500 500uL
EUR 544
Description: Primary antibody against TIMP3(Rabbit PAb), CF660R conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC680375-100 100uL
EUR 199
Description: Primary antibody against p40(Rabbit PAb), CF568 conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC680375-500 500uL
EUR 544
Description: Primary antibody against p40(Rabbit PAb), CF568 conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC680385-100 100uL
EUR 199
Description: Primary antibody against CD3e(Rabbit PAb), CF568 conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC680385-500 500uL
EUR 544
Description: Primary antibody against CD3e(Rabbit PAb), CF568 conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC680386-100 100uL
EUR 199
Description: Primary antibody against CD8a(Rabbit PAb), CF568 conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC680386-500 500uL
EUR 544
Description: Primary antibody against CD8a(Rabbit PAb), CF568 conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC680408-100 100uL
EUR 199
Description: Primary antibody against TIMP3(Rabbit PAb), CF568 conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC680408-500 500uL
EUR 544
Description: Primary antibody against TIMP3(Rabbit PAb), CF568 conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC400375-100 100uL
EUR 199
Description: Primary antibody against p40(Rabbit PAb), CF640R conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC400375-500 500uL
EUR 544
Description: Primary antibody against p40(Rabbit PAb), CF640R conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC400385-100 100uL
EUR 199
Description: Primary antibody against CD3e(Rabbit PAb), CF640R conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC400385-500 500uL
EUR 544
Description: Primary antibody against CD3e(Rabbit PAb), CF640R conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC400386-100 100uL
EUR 199
Description: Primary antibody against CD8a(Rabbit PAb), CF640R conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC400386-500 500uL
EUR 544
Description: Primary antibody against CD8a(Rabbit PAb), CF640R conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC400408-100 100uL
EUR 199
Description: Primary antibody against TIMP3(Rabbit PAb), CF640R conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC400408-500 500uL
EUR 544
Description: Primary antibody against TIMP3(Rabbit PAb), CF640R conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC430375-100 100uL
EUR 199
Description: Primary antibody against p40(Rabbit PAb), CF543 conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC430375-500 500uL
EUR 544
Description: Primary antibody against p40(Rabbit PAb), CF543 conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC430385-100 100uL
EUR 199
Description: Primary antibody against CD3e(Rabbit PAb), CF543 conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC430385-500 500uL
EUR 544
Description: Primary antibody against CD3e(Rabbit PAb), CF543 conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC430386-100 100uL
EUR 199
Description: Primary antibody against CD8a(Rabbit PAb), CF543 conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC430386-500 500uL
EUR 544
Description: Primary antibody against CD8a(Rabbit PAb), CF543 conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC430408-100 100uL
EUR 199
Description: Primary antibody against TIMP3(Rabbit PAb), CF543 conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC430408-500 500uL
EUR 544
Description: Primary antibody against TIMP3(Rabbit PAb), CF543 conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC550375-100 100uL
EUR 199
Description: Primary antibody against p40(Rabbit PAb), CF555 conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC550375-500 500uL
EUR 544
Description: Primary antibody against p40(Rabbit PAb), CF555 conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC550385-100 100uL
EUR 199
Description: Primary antibody against CD3e(Rabbit PAb), CF555 conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC550385-500 500uL
EUR 544
Description: Primary antibody against CD3e(Rabbit PAb), CF555 conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC550386-100 100uL
EUR 199
Description: Primary antibody against CD8a(Rabbit PAb), CF555 conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC550386-500 500uL
EUR 544
Description: Primary antibody against CD8a(Rabbit PAb), CF555 conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC550408-100 100uL
EUR 199
Description: Primary antibody against TIMP3(Rabbit PAb), CF555 conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC550408-500 500uL
EUR 544
Description: Primary antibody against TIMP3(Rabbit PAb), CF555 conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC040375-100 100uL
EUR 199
Description: Primary antibody against p40(Rabbit PAb), CF405S conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC040375-500 500uL
EUR 544
Description: Primary antibody against p40(Rabbit PAb), CF405S conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC040385-100 100uL
EUR 199
Description: Primary antibody against CD3e(Rabbit PAb), CF405S conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC040385-500 500uL
EUR 544
Description: Primary antibody against CD3e(Rabbit PAb), CF405S conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC040386-100 100uL
EUR 199
Description: Primary antibody against CD8a(Rabbit PAb), CF405S conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC040386-500 500uL
EUR 544
Description: Primary antibody against CD8a(Rabbit PAb), CF405S conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC040408-100 100uL
EUR 199
Description: Primary antibody against TIMP3(Rabbit PAb), CF405S conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC040408-500 500uL
EUR 544
Description: Primary antibody against TIMP3(Rabbit PAb), CF405S conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC050375-100 100uL
EUR 199
Description: Primary antibody against p40(Rabbit PAb), CF405M conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC050375-500 500uL
EUR 544
Description: Primary antibody against p40(Rabbit PAb), CF405M conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC050385-100 100uL
EUR 199
Description: Primary antibody against CD3e(Rabbit PAb), CF405M conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC050385-500 500uL
EUR 544
Description: Primary antibody against CD3e(Rabbit PAb), CF405M conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC050386-100 100uL
EUR 199
Description: Primary antibody against CD8a(Rabbit PAb), CF405M conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC050386-500 500uL
EUR 544
Description: Primary antibody against CD8a(Rabbit PAb), CF405M conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC050408-100 100uL
EUR 199
Description: Primary antibody against TIMP3(Rabbit PAb), CF405M conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC050408-500 500uL
EUR 544
Description: Primary antibody against TIMP3(Rabbit PAb), CF405M conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC470375-100 100uL
EUR 199
Description: Primary antibody against p40(Rabbit PAb), CF647 conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC470375-500 500uL
EUR 544
Description: Primary antibody against p40(Rabbit PAb), CF647 conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC470385-100 100uL
EUR 199
Description: Primary antibody against CD3e(Rabbit PAb), CF647 conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC470385-500 500uL
EUR 544
Description: Primary antibody against CD3e(Rabbit PAb), CF647 conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC470386-100 100uL
EUR 199
Description: Primary antibody against CD8a(Rabbit PAb), CF647 conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC470386-500 500uL
EUR 544
Description: Primary antibody against CD8a(Rabbit PAb), CF647 conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC470408-100 100uL
EUR 199
Description: Primary antibody against TIMP3(Rabbit PAb), CF647 conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC470408-500 500uL
EUR 544
Description: Primary antibody against TIMP3(Rabbit PAb), CF647 conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNUM0375-50 50uL
EUR 395
Description: Primary antibody against p40(Rabbit PAb), 1mg/mL
CD3e(Rabbit PAb) Antibody
BNUM0385-50 50uL
EUR 395
Description: Primary antibody against CD3e(Rabbit PAb), 1mg/mL
CD8a(Rabbit PAb) Antibody
BNUM0386-50 50uL
EUR 395
Description: Primary antibody against CD8a(Rabbit PAb), 1mg/mL
TIMP3(Rabbit PAb) Antibody
BNUM0408-50 50uL
EUR 395
Description: Primary antibody against TIMP3(Rabbit PAb), 1mg/mL
p40(Rabbit PAb) Antibody
BNC700375-100 100uL
EUR 199
Description: Primary antibody against p40(Rabbit PAb), CF770 conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC700375-500 500uL
EUR 544
Description: Primary antibody against p40(Rabbit PAb), CF770 conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC700385-100 100uL
EUR 199
Description: Primary antibody against CD3e(Rabbit PAb), CF770 conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC700385-500 500uL
EUR 544
Description: Primary antibody against CD3e(Rabbit PAb), CF770 conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC700386-100 100uL
EUR 199
Description: Primary antibody against CD8a(Rabbit PAb), CF770 conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC700386-500 500uL
EUR 544
Description: Primary antibody against CD8a(Rabbit PAb), CF770 conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC700408-100 100uL
EUR 199
Description: Primary antibody against TIMP3(Rabbit PAb), CF770 conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC700408-500 500uL
EUR 544
Description: Primary antibody against TIMP3(Rabbit PAb), CF770 conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC940375-100 100uL
EUR 199
Description: Primary antibody against p40(Rabbit PAb), CF594 conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC940375-500 500uL
EUR 544
Description: Primary antibody against p40(Rabbit PAb), CF594 conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC940385-100 100uL
EUR 199
Description: Primary antibody against CD3e(Rabbit PAb), CF594 conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC940385-500 500uL
EUR 544
Description: Primary antibody against CD3e(Rabbit PAb), CF594 conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC940386-100 100uL
EUR 199
Description: Primary antibody against CD8a(Rabbit PAb), CF594 conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC940386-500 500uL
EUR 544
Description: Primary antibody against CD8a(Rabbit PAb), CF594 conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC940408-100 100uL
EUR 199
Description: Primary antibody against TIMP3(Rabbit PAb), CF594 conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC940408-500 500uL
EUR 544
Description: Primary antibody against TIMP3(Rabbit PAb), CF594 conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNCH0375-100 100uL
EUR 199
Description: Primary antibody against p40(Rabbit PAb), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNCH0375-500 500uL
EUR 544
Description: Primary antibody against p40(Rabbit PAb), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNCH0385-100 100uL
EUR 199
Description: Primary antibody against CD3e(Rabbit PAb), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNCH0385-500 500uL
EUR 544
Description: Primary antibody against CD3e(Rabbit PAb), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNCH0386-100 100uL
EUR 199
Description: Primary antibody against CD8a(Rabbit PAb), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNCH0386-500 500uL
EUR 544
Description: Primary antibody against CD8a(Rabbit PAb), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNCH0408-100 100uL
EUR 199
Description: Primary antibody against TIMP3(Rabbit PAb), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNCH0408-500 500uL
EUR 544
Description: Primary antibody against TIMP3(Rabbit PAb), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC800375-100 100uL
EUR 199
Description: Primary antibody against p40(Rabbit PAb), CF680 conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC800375-500 500uL
EUR 544
Description: Primary antibody against p40(Rabbit PAb), CF680 conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC800385-100 100uL
EUR 199
Description: Primary antibody against CD3e(Rabbit PAb), CF680 conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC800385-500 500uL
EUR 544
Description: Primary antibody against CD3e(Rabbit PAb), CF680 conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC800386-100 100uL
EUR 199
Description: Primary antibody against CD8a(Rabbit PAb), CF680 conjugate, Concentration: 0.1mg/mL
CD8a(Rabbit PAb) Antibody
BNC800386-500 500uL
EUR 544
Description: Primary antibody against CD8a(Rabbit PAb), CF680 conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC800408-100 100uL
EUR 199
Description: Primary antibody against TIMP3(Rabbit PAb), CF680 conjugate, Concentration: 0.1mg/mL
TIMP3(Rabbit PAb) Antibody
BNC800408-500 500uL
EUR 544
Description: Primary antibody against TIMP3(Rabbit PAb), CF680 conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC810375-100 100uL
EUR 199
Description: Primary antibody against p40(Rabbit PAb), CF680R conjugate, Concentration: 0.1mg/mL
p40(Rabbit PAb) Antibody
BNC810375-500 500uL
EUR 544
Description: Primary antibody against p40(Rabbit PAb), CF680R conjugate, Concentration: 0.1mg/mL
CD3e(Rabbit PAb) Antibody
BNC810385-100 100uL
EUR 199
Description: Primary antibody against CD3e(Rabbit PAb), CF680R conjugate, Concentration: 0.1mg/mL

We carried out a complete search in PubMed/Medline, Net of Science, Scopus, Google Scholar and Embase, from the inception of those databases till January 2021. In whole, 11 papers had been included based mostly on the eligible standards in our meta-analysis.

LEAVE A REPLY

Please enter your comment!
Please enter your name here